Application Information

This drug has been submitted to the FDA under the reference 207533/001.

Names and composition

"ARISTADA" is the commercial name of a drug composed of ARIPIPRAZOLE LAUROXIL.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
207533/001 ARISTADA ARIPIPRAZOLE LAUROXIL SUSPENSION, EXTENDED RELEASE/INTRAMUSCULAR 441MG per 1.6ML (275.63MG per ML)
207533/002 ARISTADA ARIPIPRAZOLE LAUROXIL SUSPENSION, EXTENDED RELEASE/INTRAMUSCULAR 662MG per 2.4ML (275.83MG per ML)
207533/003 ARISTADA ARIPIPRAZOLE LAUROXIL SUSPENSION, EXTENDED RELEASE/INTRAMUSCULAR 882MG per 3.2ML (275.63MG per ML)
207533/004 ARISTADA ARIPIPRAZOLE LAUROXIL SUSPENSION, EXTENDED RELEASE/INTRAMUSCULAR 1064MG per 3.9ML (272.82MG per ML)

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
207533/001 ARISTADA ARIPIPRAZOLE LAUROXIL SUSPENSION, EXTENDED RELEASE/INTRAMUSCULAR 441MG per 1.6ML (275.63MG per ML)
207533/002 ARISTADA ARIPIPRAZOLE LAUROXIL SUSPENSION, EXTENDED RELEASE/INTRAMUSCULAR 662MG per 2.4ML (275.83MG per ML)
207533/003 ARISTADA ARIPIPRAZOLE LAUROXIL SUSPENSION, EXTENDED RELEASE/INTRAMUSCULAR 882MG per 3.2ML (275.63MG per ML)
207533/004 ARISTADA ARIPIPRAZOLE LAUROXIL SUSPENSION, EXTENDED RELEASE/INTRAMUSCULAR 1064MG per 3.9ML (272.82MG per ML)

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved